ATE318922T1 - Zielgerichtete integration in chromosomen mittels retroviraler vektoren - Google Patents

Zielgerichtete integration in chromosomen mittels retroviraler vektoren

Info

Publication number
ATE318922T1
ATE318922T1 AT99932760T AT99932760T ATE318922T1 AT E318922 T1 ATE318922 T1 AT E318922T1 AT 99932760 T AT99932760 T AT 99932760T AT 99932760 T AT99932760 T AT 99932760T AT E318922 T1 ATE318922 T1 AT E318922T1
Authority
AT
Austria
Prior art keywords
chromosomes
retroviral vectors
targeted integration
gene therapy
relates
Prior art date
Application number
AT99932760T
Other languages
English (en)
Inventor
Walter Guenzburg
Brian Salmons
Sabine Strauss-Goller
Dieter Klein
Original Assignee
Inst Virologie Teilrechtsfaehi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Virologie Teilrechtsfaehi filed Critical Inst Virologie Teilrechtsfaehi
Application granted granted Critical
Publication of ATE318922T1 publication Critical patent/ATE318922T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Complex Calculations (AREA)
  • Feedback Control In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compression Or Coding Systems Of Tv Signals (AREA)
  • Electrotherapy Devices (AREA)
AT99932760T 1998-07-01 1999-06-30 Zielgerichtete integration in chromosomen mittels retroviraler vektoren ATE318922T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA199801016 1998-07-01

Publications (1)

Publication Number Publication Date
ATE318922T1 true ATE318922T1 (de) 2006-03-15

Family

ID=8100053

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99932760T ATE318922T1 (de) 1998-07-01 1999-06-30 Zielgerichtete integration in chromosomen mittels retroviraler vektoren

Country Status (7)

Country Link
US (1) US6656727B2 (de)
EP (1) EP1092035B1 (de)
JP (1) JP2002519069A (de)
AT (1) ATE318922T1 (de)
AU (1) AU4903099A (de)
DE (1) DE69930123T2 (de)
WO (1) WO2000001835A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030224415A1 (en) * 2001-06-29 2003-12-04 Gala Design, Inc. Selection free growth of host cells containing multiple integrating vectors
AU2001271614B2 (en) * 2000-07-03 2007-05-31 Catalent Pharma Solutions, Llc Host cells containing multiple integrating vectors
US20040235173A1 (en) * 2000-07-03 2004-11-25 Gala Design, Inc. Production of host cells containing multiple integrating vectors by serial transduction
CA2413156C (en) * 2000-07-03 2009-08-18 Gala Design, Inc. Expression vectors
US7384738B2 (en) * 2002-03-28 2008-06-10 Bremel Robert D Retrovirus-based genomic screening
US20040038304A1 (en) * 2002-03-28 2004-02-26 Gala Design, Inc. Antibody libraries
US20050221429A1 (en) * 2004-01-16 2005-10-06 Cardinal Health Pts, Llc Host cells containing multiple integrating vectors comprising an amplifiable marker
US20060233757A1 (en) * 2004-08-27 2006-10-19 Wendy Maury Vectors with viral insulators
KR20070053732A (ko) * 2004-09-02 2007-05-25 와이어쓰 단백질 생산 시스템 및 생산 방법
US7470777B2 (en) * 2004-12-22 2008-12-30 Iowa State University Research Foundation, Inc. Compositions and methods related to modified retroviral vectors for restricted, site specific integration

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856152A (en) * 1994-10-28 1999-01-05 The Trustees Of The University Of Pennsylvania Hybrid adenovirus-AAV vector and methods of use therefor
US5650309A (en) * 1995-05-16 1997-07-22 The Regents Of The University Of California Viral vectors
US5801030A (en) * 1995-09-01 1998-09-01 Genvec, Inc. Methods and vectors for site-specific recombination
WO1998042856A1 (en) * 1997-03-21 1998-10-01 Enzo Therapeutics, Inc., A Fully Owned Subsidiary Of Enzo Biochem, Inc. Vectors and viral vectors, and packaging cell lines for propagating same
US6251677B1 (en) * 1997-08-25 2001-06-26 The Trustees Of The University Of Pennsylvania Hybrid adenovirus-AAV virus and methods of use thereof

Also Published As

Publication number Publication date
WO2000001835A2 (en) 2000-01-13
DE69930123T2 (de) 2006-10-12
AU4903099A (en) 2000-01-24
US20010043921A1 (en) 2001-11-22
EP1092035A2 (de) 2001-04-18
WO2000001835A3 (en) 2000-04-06
JP2002519069A (ja) 2002-07-02
EP1092035B1 (de) 2006-03-01
US6656727B2 (en) 2003-12-02
DE69930123D1 (de) 2006-04-27

Similar Documents

Publication Publication Date Title
SG165153A1 (en) Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
ATE335086T1 (de) Künstliche chromosomen, die die genetische information für die bildung von rekombinantem virus enthalten
GB2405406B (en) Viral vectors
DE69930123D1 (de) Zielgerichtete integration in chromosomen mittels retroviraler vektoren
DE69619110T2 (de) Adenovirale vektoren für die gentherapie
ATE382694T1 (de) Vektoren und methoden zum gentransfer in zellen
ATE320500T1 (de) Nukleotid-sequenzen zur kontrolle der exprimierung von dns-sequenzen in einem zellulärem wirt
TR200103711T2 (tr) Homeostas ve adaptasyondaki proteinleri kodlayan corynebacterıum glutamıcum genleri.
ATE510920T1 (de) Dna-sequenzen zur regulation der transkription
DE60023860D1 (de) Verfahren zur herstellung von rekombinanten peptiden
DE69840439D1 (de) Zielgerichtete genveraenderung mit parvoviralen vektoren
ATE365807T1 (de) Hepatitis b virus vektoren für gentherapie
ES2152313T3 (es) Gen grb-3-3, sus variantes y sus utilizaciones.
DE69928395D1 (de) Cyclin-e2 proteine und dafür kodierende gene
ATE532861T1 (de) Expressionsvektor
ES2168459T3 (es) Secuencias amplificadoras derivadas del gen de la desmina, vectores que llevan estas secuencias y sus utilizaciones para la produccion de proteinas.
FI972325A0 (fi) Rekombinatkonstruktion foer oekning av genexpression hos vaexter
ATE288488T1 (de) Zusammensetzungen und verfahren zur eliminierung unerwünschter zellen
ZA200404424B (en) Genes encoding for genetic stability, gene expression and folding proteins.
DE50304957D1 (de) Rekombinante virale vektoren zur tetracyclinregulierbaren genexpression
GB2358865A (en) Targeted gene modification by parvoviral vectors
DE60031539D1 (de) Mutiertes nurr1 gen
HUP0400915A2 (hu) Növényi reprodukciós proteinek
ATE311205T1 (de) Verwendung von viralen vektoren und geladenen molekülen für die gentherapie
DE69636737D1 (de) Neues immunoregulatorisches protein lst-1

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1092035

Country of ref document: EP

REN Ceased due to non-payment of the annual fee